The present invention relates to the use of a glial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/or a nucleic acid containing at least a nucleotide sequence encoding the primary amino acid sequence of GDNF or the functionally active derivative or part thereof and/or of the agonist for the manufacture of a pharmaceutical composition for epidermal and stromal wound healing.
申请公布号
WO0130375(A2)
申请公布日期
2001.05.03
申请号
WO2000EP10674
申请日期
2000.10.30
申请人
BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA MBH;HANKE, MICHAEL;KRUSE, FRIEDRICH;PAULISTA, MICHAEL;POHL, JENS